The expression and clinical correlation of molecular markers in 128 patients diagnosed with triple-negative breast cancer (TNBC).Immunohistochemistry was used to assess markers including Ki-67, p53, EGFR and CK5/6. This evidence concerns the gene EGFR and triple-negative breast carcinoma.